about
Comparison of circular RNA prediction tools.A role for the basic patch and the C terminus of RanGTP in regulating the dynamic interactions with importin beta, CRM1 and RanBP1.The specificity of the CRM1-Rev nuclear export signal interaction is mediated by RanGTP.RNA interactions in the 5' region of the HIV-1 genomeGenomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitroStructure of the HIV-1 Rev response element alone and in complex with regulator of virion (Rev) studied by atomic force microscopyIn vitro interaction between human immunodeficiency virus type 1 Rev protein and splicing factor ASF/SF2-associated protein, p32Translational repression of E2F1 mRNA in carcinoma in situ and normal testis correlates with expression of the miR-17-92 clusterProtein footprinting approach to mapping DNA binding sites of two archaeal homing enzymes: evidence for a two-domain protein structure.Endosomal trafficking of HIV-1 gag and genomic RNAs regulates viral egress.N,O6-partially acetylated chitosan nanoparticles hydrophobically-modified for controlled release of steroids and vitamin E.RNA sequencing of synaptic and cytoplasmic Upf1-bound transcripts supports contribution of nonsense-mediated decay to epileptogenesis.Strategies to identify potential therapeutic target sites in RNA.Small RNA sequencing reveals metastasis-related microRNAs in lung adenocarcinomaRepair of a Rev-minus human immunodeficiency virus type 1 mutant by activation of a cryptic splice site.Multithreaded comparative RNA secondary structure prediction using stochastic context-free grammarsProtection and Systemic Translocation of siRNA Following Oral Administration of Chitosan/siRNA Nanoparticles.Chitosan hydrogel as siRNA vector for prolonged gene silencing.CRM1 mediates the export of ADAR1 through a nuclear export signal within the Z-DNA binding domain.Megalin-mediated specific uptake of chitosan/siRNA nanoparticles in mouse kidney proximal tubule epithelial cells enables AQP1 gene silencing.MicroRNA alterations and associated aberrant DNA methylation patterns across multiple sample types in oral squamous cell carcinoma.SF2/ASF binds to a splicing enhancer in the third HIV-1 tat exon and stimulates U2AF binding independently of the RS domain.Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer.The RNA splicing factor ASF/SF2 inhibits human topoisomerase I mediated DNA relaxation.miRdentify: high stringency miRNA predictor identifies several novel animal miRNAssiRNA nanoparticle functionalization of nanostructured scaffolds enables controlled multilineage differentiation of stem cells.A distant cis acting intronic element induces site-selective RNA editing.The sequence complementarity between HIV-1 5' splice site SD4 and U1 snRNA determines the steady-state level of an unstable env pre-mRNA.Circular RNA and miR-7 in cancer.Serum-stable RNA aptamers to urokinase-type plasminogen activator blocking receptor binding.PPfold 3.0: fast RNA secondary structure prediction using phylogeny and auxiliary data.A synthetic HIV-1 Rev inhibitor interfering with the CRM1-mediated nuclear export.Construction of a fuzzy and Boolean logic gates based on DNA.Characterising RNA secondary structure space using information entropymiRConnect 2.0: identification of oncogenic, antagonistic miRNA families in three human cancersMapping the RNA binding sites for human immunodeficiency virus type-1 gag and NC proteins within the complete HIV-1 and -2 untranslated leader regions.Chitosan/siRNA nanoparticles targeting cyclooxygenase type 2 attenuate unilateral ureteral obstruction-induced kidney injury in mice.miR-145 induces caspase-dependent and -independent cell death in urothelial cancer cell lines with targeting of an expression signature present in Ta bladder tumors.The strength of the HIV-1 3' splice sites affects Rev function.Chitosan/siRNA functionalized titanium surface via a layer-by-layer approach for in vitro sustained gene silencing and osteogenic promotion.
P50
Q27324774-6AE5EE06-C689-4CCC-ADBF-3727EBD0099AQ27863681-F73BD593-A237-4563-80BB-C3074C6B8094Q27867724-E9C5F349-153B-45A9-B255-0EE32C4628D5Q28241918-017626E9-13C8-48FD-B9D1-17CCF243C6A6Q28247046-EA29CCC7-3E9B-4A27-A82F-619D0AA758C3Q28251127-A2B66814-138F-4141-BDEC-B557FBDA34EAQ28278287-E875BE0F-7AAB-44C1-A8A2-891C6BF4B33CQ28283064-D7EBE4CE-69F5-41CE-821F-6A3BA4775941Q30425809-8B8E3C99-A0CC-4EFB-AC8D-00EDFE890CCCQ30490064-D1C20167-ABE7-4758-B353-8FC046B6D1F6Q30572449-DF7F13D1-4188-4E97-A26F-A82F4D6BFAD5Q30836611-B3AB35A2-8D54-4A18-8C7A-FCCB13A46E18Q33238857-5BF05707-5605-4472-BFD7-A13CBE525390Q33688925-C3AFB0B9-38BC-4309-9FAF-45A59E1CAAA8Q33839005-728F915B-4A8C-4DB2-B656-B2F3A155D95AQ33875915-5B85BDF9-28BF-4322-A5A3-627CF31A9AE4Q33902729-476C00D9-C840-4DBE-BBDA-72235EB877CCQ33925196-93731C91-35E6-4C7B-AD77-69AE93245A90Q34012799-3A08718B-61DB-46A9-B3AB-89C950FD824FQ34080235-38F47CA9-1894-439B-80BC-89CFE573B8FAQ34087915-CAE117ED-1030-42E3-9FE7-4D9433A06F18Q34092879-6D1174C6-5041-49A6-98A2-0C28EB07C733Q34115748-C1C515F1-2EAD-4E50-8357-59A33AF88447Q34150881-7AC8DF8A-A3D8-4203-BB86-BC052E6CDD94Q34249673-88EE0F02-B5B7-40F9-880A-3310CE0E0008Q34343747-2411A204-5821-43BE-908A-2BDAC5F7B3D4Q34357627-74FA2F24-39E8-4662-B102-51FDE0E7FB6EQ34363471-ACEBA305-AC08-4A22-A85E-DCE994C219D4Q34369523-84BF9D55-AF09-4A54-A67F-14E59242EBAAQ34370103-703964C8-DF5E-4297-8A4B-A16DF9A4C539Q34373242-C0B1962F-F894-4E46-90D9-764B498C0326Q34394284-6C20B808-F1A1-41E9-8AE3-835042177A5BQ34456894-A8F39573-63DD-465F-A00A-C2E33774F506Q34569692-41980F6E-BC03-422F-9997-EC9AE56BA62CQ34623368-59964FB3-DF06-498F-A6EA-5E972FE2F1B0Q34673247-DF9A277F-13A8-4F0A-B041-3E44102C26BCQ34785218-C170BE45-0E2F-41D7-988D-9EE34067CE7EQ35013059-84CCDE80-3A25-46BE-9A07-FB6ADE9C1F0EQ35220043-9F320FBB-C836-44DE-9FFA-A9B45353D158Q35229022-C668F266-19BD-437C-857F-5683B6787506
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
J Kjems
@ast
J Kjems
@en
J Kjems
@es
J Kjems
@nl
J Kjems
@sl
type
label
J Kjems
@ast
J Kjems
@en
J Kjems
@es
J Kjems
@nl
J Kjems
@sl
prefLabel
J Kjems
@ast
J Kjems
@en
J Kjems
@es
J Kjems
@nl
J Kjems
@sl
P106
P1153
35426050200
P31
P496
0000-0003-4128-9317